Assignee
CELLULAR BIOMEDICINE GROUP INC
US·4 granted patents·9 pending applications·21 citations·filing 2019–2023
Top patents by PatentIndex Score
13 records- 0195US11633430B2Combined chimeric antigen receptor targeting CD19 and CD20 and application thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Apr 25, 2023·7 cites·5 claims
- 0295US11618778B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Apr 4, 2023·7 cites·6 claims
- 0395US11608369B2Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2022·Granted Mar 21, 2023·7 cites·6 claims
- 0481US2023242613A1Construction of chimeric antigen receptor targeting cd20 antigen and activity identification of engineered t cells thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2023·Application pending·0 cites
- 0581US2024139243A1Combined chimeric antigen receptor targeting CD19 and CD20 and application thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2023·Application pending·0 cites
- 0664US11697848B2Reagent and method for fluorescence quantitative real-time PCR detection of RCLCELLULAR BIOMEDICINE GROUP INC·Filed 2019·Granted Jul 11, 2023·0 cites·7 claims
- 0757US2024115605A1Chimeric antigen receptors targeting cd20CELLULAR BIOMEDICINE GROUP INC·Filed 2022·Application pending·0 cites
- 0856US2023141382A1Compositions for preservation of viral vectorsCELLULAR BIOMEDICINE GROUP INC·Filed 2021·Application pending·0 cites
- 0955US2023340398A1Methods for lysing bacterial cellsCELLULAR BIOMEDICINE GROUP INC·Filed 2021·Application pending·0 cites
- 1054US2023304108A1Method for determining titer of rna viral vectorsCELLULAR BIOMEDICINE GROUP INC·Filed 2021·Application pending·0 cites
- 1153US2023212255A1Combined chimeric antigen receptor targeting cd19 and cd20 and applications thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2021·Application pending·0 cites
- 1250US2023104705A1Combined chimeric antigen receptor targeting cd19 and cd20 and application thereofCELLULAR BIOMEDICINE GROUP INC·Filed 2020·Application pending·0 cites
- 1349US2023257704A1Methods for preparation of immune cellsCELLULAR BIOMEDICINE GROUP INC·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when CELLULAR BIOMEDICINE GROUP INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →